SCHEMBL25627482

SCHEMBL25627482

COc1cc2ccc(C(C)C)cc2cc1OC

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.57
CYP2C9 P11712 2/20 0.51
CYP17A1 P05093 1/20 0.51
CYP2C19 P33261 1/20 0.51
HDAC4 P56524 1/20 0.47
HDAC8 Q9BY41 1/20 0.47
ABCB11 O95342 1/20 0.44
UGT2B7 P16662 1/20 0.44
PTGS2 P35354 3/20 0.43
AKR1C3 P42330 3/20 0.43
AKR1C2 P52895 3/20 0.43
PTGS1 P23219 2/20 0.43
TSHR P16473 2/20 0.43
CDC42 P60953 1/20 0.43
RAC1 P63000 1/20 0.43
SLC22A6 Q4U2R8 1/20 0.43
CYP3A4 P08684 3/20 0.43
CDK5 Q00535 1/20 0.42
CDK5R1 Q15078 1/20 0.42
LMNA P02545 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22185812 0.87 CYP1A2 (0.47) CYP1A2CYP2C9CYP17A1CYP2C19HDAC4
SCHEMBL14772211 0.84 CYP1A2 (0.44) CYP1A2CYP2C9CYP17A1CYP2C19HDAC4
SCHEMBL15701616 0.83 ABCB11 (0.62) CYP1A2CYP2C9ABCB11PTGS2AKR1C3
SCHEMBL12498465 0.82 CYP1A2 (0.53) CYP1A2CYP2C9CYP17A1CYP2C19ABCB11
SCHEMBL15003307 0.82 UGT2B7 (0.54) CYP1A2ABCB11UGT2B7PTGS2AKR1C3
SCHEMBL4832080 0.82 UGT2B7 (0.52) CYP1A2HDAC4HDAC8UGT2B7PTGS1
SCHEMBL181347 0.82 UGT2B7 (0.58) CYP1A2ABCB11UGT2B7PTGS2AKR1C3
SCHEMBL30031337 0.82 UGT2B7 (0.58) CYP1A2ABCB11UGT2B7PTGS2AKR1C3
SCHEMBL13766367 0.81 MAPT (0.52) CYP1A2CYP2C9CYP17A1CYP2C19HDAC4
SCHEMBL487168 0.81 ABCB11 (0.65) CYP1A2CYP2C9ABCB11PTGS2AKR1C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230167081-A1 5-AMINO-2-PIPERIDINON-3-YL-1-OXOISOINDOLINE DERIVATIVES FOR DEGRADATION OF IKZF2 DEGRADERS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2023-06-01 US disclosed
US-20230167081-A1 5-AMINO-2-PIPERIDINON-3-YL-1-OXOISOINDOLINE DERIVATIVES FOR DEGRADATION OF IKZF2 DEGRADERS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2023-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167081-A1 5-AMINO-2-PIPERIDINON-3-YL-1-OXOISOINDOLINE DERIVATIVES FOR DEGRADATION OF IKZF2 DEGRADERS IKZF1, IKZF3, IKZF2 CYP1A2 2512/4885CYP2C9 4365/4885CYP17A1 4556/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.